Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03642119 · ClinicalTrials.gov registry record
Validation of an Objective Instrument to Measure Hot Flashes During Menopause
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Terminated
- Registry status
- 12
- Enrollment target
NCT03642119: Clinical Trial study, sponsored by Pennington Biomedical Research Center.
NCT03642119 is a clinical trial that was terminated before completion, run by Pennington Biomedical Research Center. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03642119 was terminated before completion, sponsored by Pennington Biomedical Research Center.
- TERMINATED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The overarching aim of this study is to assess the validity of the iButton®, a dual temperature and humidity sensing device (DS1923; Maxim IntegratedTM), as an objective method to assess hot flash incidence and dynamics in both a real world (ambulatory) and controlled (laboratory) setting. This study will test the overarching hypothesis that both self-report hot flashes in both an ambulatory and laboratory setting will correlate (confirm) the temperature and humidity sensing observed via the iButton® technology.
Primary Outcome
Skin temperatures will be continually monitored at 2 sites: the sternum (chest) and forearm, using iButton® technology during a single hot flash that is stimulated at the laboratory visit.
Interventions
- DEVICE iButton®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-09-07 |
| Est. Completion | 2022-09-19 |
Why NCT03642119 stopped before completion
NCT03642119 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which iButton® is the first listed.
NCT03642119 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03642119 about?
NCT03642119 is a clinical study titled "Validation of an Objective Instrument to Measure Hot Flashes During Menopause". The overarching aim of this study is to assess the validity of the iButton®, a dual temperature and humidity sensing device (DS1923; Maxim IntegratedTM), as an objective method to assess hot flash incidence and dynamics in both a real world (ambulatory) and controlled (laboratory) setting. This stud...
What is the current status of trial NCT03642119?
This trial is currently terminated. The enrollment target is 12 participants. The study started on 2018-09-07. Estimated completion is 2022-09-19.
What interventions are being tested in trial NCT03642119?
The interventions under investigation include: iButton® (DEVICE).
Who is sponsoring clinical trial NCT03642119?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI